Shannon Campbell
Vermögen: 15 780 $ am 31.10.2026
Vermögen: 15 780 $ am 31.10.2026
Shannon Campbell is currently Director at Zentalis Pharmaceuticals, Inc. starting in 2026, Independent Director at Black Diamond Therapeutics, Inc. starting in 2024, and Independent Director at Hansa Biopharma AB starting in 2026.
Former roles include Chief Commercial Officer & Executive VP at Merus NV from 2022 to 2026, and Vice President & General Manager-Oncology at Bayer HealthCare Pharmaceuticals, Inc. from 2005 to 2017.
Education includes undergraduate studies at Ithaca College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.06.2026 | 8 865 ( 0,02 % ) | 15 780 $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.04.2024 |
| ZENTALIS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 22.05.2026 |
| HANSA BIOPHARMA AB | Direktor/Vorstandsmitglied | 22.09.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | 01.01.2026 |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Corporate Officer/Principal | 01.01.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Ithaca College
Ithaca College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen